Amanote Research
Register
Sign In
Dual PI3K/mTORC1 Targeting Suppresses HER2+ Brain Metastasis Xenografts
Cancer Discovery
- United States
doi 10.1158/2159-8290.cd-rw2016-112
Full Text
Open PDF
Abstract
Available in
full text
Categories
Oncology
Date
June 20, 2016
Authors
Unknown
Publisher
American Association for Cancer Research (AACR)
Related search
EGFR and HER2 Signaling in Breast Cancer Brain Metastasis
Frontiers in Bioscience - Elite
Immunology
Molecular Biology
Biochemistry
Microbiology
Medicine
Genetics
MicroRNA-146a Suppresses Metastatic Activity in Brain Metastasis
Molecules and Cells
Medicine
Cell Biology
Molecular Biology
miR‑202 Suppresses Prostate Cancer Growth and Metastasis by Targeting PIK3CA
Experimental and Therapeutic Medicine
Medicine
Cancer Research
Immunology
Microbiology
Spatiotemporal Targeting of a Dual-Ligand Nanoparticle to Cancer Metastasis
ACS Nano
Materials Science
Nanoscience
Engineering
Nanotechnology
Astronomy
Physics
HER2-positive Breast Cancer With Brain Metastasis, Long Responder to Lapatinib Therapy
AboutOpen
Dual Targeting of MEK and PI3K Pathways Attenuates Established and Progressive Pulmonary Fibrosis
PLoS ONE
Multidisciplinary
mTORC1 Suppresses Consumption of Extracellular Proteins as Nutrients
Cancer Discovery
Oncology
The Biology and Therapy of Brain Metastasis: Targeting the Astrocytes
Tumor Biology
Medicine
Cancer Research
MicroRNA-101 Inhibits Growth and Metastasis of Human Ovarian Cancer Cells by Targeting PI3K/AKT
Archives of Medical Science
Medicine
